Laura & Isaac Perlmutter Cancer Center - NYU ACC — New York, New York

Laura & Isaac Perlmutter Cancer Center - NYU ACC is a clinical research site located in New York, New York, United States 10032-3726.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Laura & Isaac Perlmutter Cancer Center - NYU ACC has participated in 4 clinical trials with 4 currently active.

Therapeutic areas: H3 K27M, Glioma, Melanoma.

Sponsors: Jazz Pharmaceuticals, Pfizer, Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Laura & Isaac Perlmutter Cancer Center - NYU ACC?

Laura & Isaac Perlmutter Cancer Center - NYU ACC has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Laura & Isaac Perlmutter Cancer Center - NYU ACC conducted?

Laura & Isaac Perlmutter Cancer Center - NYU ACC has 4 clinical trials on record, with 4 currently active. Their work covers H3 K27M, Glioma, Melanoma.

Is Laura & Isaac Perlmutter Cancer Center - NYU ACC accredited by Crixeo Health?

Yes — Laura & Isaac Perlmutter Cancer Center - NYU ACC holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Laura & Isaac Perlmutter Cancer Center - NYU ACC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.